Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease?
about
Nutritional interventions for survivors of childhood cancerFeasibility and initial effectiveness of home exercise during maintenance therapy for childhood acute lymphoblastic leukemiaCardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor studyAssessment of Obesity and Hepatic Late Adverse Effects in the Egyptian Survivors of Pediatric Acute Lymphoblastic Leukemia: a Single Center Study.Health behaviors, medical care, and interventions to promote healthy living in the Childhood Cancer Survivor Study cohort.Diet and physical activity in childhood cancer survivors: a review of the literature.Predictors of being overweight or obese in survivors of pediatric acute lymphoblastic leukemia (ALL).Comparison of childhood cancer survivors' nutritional intake with US dietary guidelines.Obesity in Childhood Cancer Survivors: Call for Early Weight Management.Abdominal aortic calcification in young adult survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort studyDo Childhood Cancer Survivors Meet the Diet and Physical Activity Guidelines? A Review of Guidelines and Literature.Cranial radiotherapy predisposes to abdominal adiposity in survivors of childhood acute lymphocytic leukemia.Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease.Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia.Endocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia.Obesity and insulin resistance in pediatric acute lymphoblastic leukemia worsens during maintenance therapy.Adiposity in childhood cancer survivors: insights into obesity physiopathology.Evaluation of fitness levels of children with a diagnosis of acute leukemia and lymphoma after completion of chemotherapy and autologous hematopoietic stem cell transplantation.Metabolic syndrome in patients with hematological diseases.Early Nutrition and Physical Activity Interventions in Childhood Cancer Survivors.Pharmacogenetics of anthracyclines.Nutritional interventions for survivors of childhood cancer.Changes in body mass index in long-term childhood cancer survivors.Carotid intima-media thickness in young survivors of childhood cancer.Immunity in young adult survivors of childhood leukemia is similar to the elderly rather than age-matched controls: Role of cytomegalovirus.Blood pressure and body composition in long-term survivors of childhood acute lymphoblastic leukemia.Asymmetric dimethylarginine in hematological malignancies: a preliminary study.Genomic determinants of long-term cardiometabolic complications in childhood acute lymphoblastic leukemia survivors.Cardiometabolic Risk Factors in Childhood, Adolescent and Young Adult Survivors of Acute Lymphoblastic Leukemia - A Petale Cohort.Prevalence and characteristics of metabolic syndrome in adults from the French childhood leukemia survivors' cohort: A comparison with controls from the French population.Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a prospective registry.Abnormal correlation of circulating endothelial progenitor cells and endothelin-1 concentration may contribute to the development of arterial hypertension in childhood acute lymphoblastic leukemia survivors.Gastrointestinal cancer educational case series: management of metastatic adenocarcinoma of unknown primary origin in a Ph+ ALL survivor.Overweight and obesity management strategies in survivors of paediatric acute lymphoblastic leukaemia: a systematic review protocol.
P2860
Q24201535-01D9806E-4E34-4DD2-8815-99E83692C8FCQ30596383-E9D7E03C-5F86-431D-B3E2-25857D273550Q33585366-7359D780-C5F0-41E7-AD00-CCE96F8620BEQ33642238-8423977C-F777-4101-BBA8-326C2D81EA12Q34016380-A11707B7-D106-4D21-A023-DA0AB4D69A77Q34109270-41FE8430-E41B-4826-B4F9-1933E60E2DA8Q35618728-ECF9A062-BAA9-4E37-84B5-5D61ABBAEB2AQ35789041-445C87FE-1278-4DC9-8FA5-796B9225BFD5Q36033715-DA6281AF-FFC7-4648-A8A2-E244DB7E1ADEQ36067209-06D10BB9-1B8E-43E1-9EA8-4095E85BB8BBQ36673095-052CE0BA-8171-4608-BCD9-D2FB0BC26CBEQ36769572-67EEE460-E2C9-4750-9FB5-0A1DAF4A5353Q37004049-54CC5785-CA7F-478D-95F8-C02691FAB259Q37051195-357C5DB0-894E-40D9-84DE-73A52BE25AA5Q37426570-FAF7A349-F28D-46A6-864B-2A350F0F764EQ37438214-0DAF3A46-D465-4E00-A422-E51A857B419EQ37494294-CEEDF793-56B6-4E7A-B8DD-330D4A0702A6Q37703397-EED60E84-EF70-49C0-832A-DC1D524E8AEFQ38044776-D96652B9-4371-42ED-8265-98973B9CCDA1Q38689505-E76C4EE8-4F4B-49AF-AF09-2CE082A6352BQ38856218-4BB4CCAD-5DD2-4A8B-B97B-6EEC0EEC5F58Q38933260-BF498970-14AC-4F70-BDA2-3F20AB6A353CQ38972814-2600B4F1-E53A-4040-8C71-E59ED21C59C3Q39460349-91C8DCC0-B051-4BDC-A086-849370B1DE11Q39808961-C492967E-61CE-491E-9AF7-E7B60BD253F4Q43694895-96B04667-2536-4B55-A5AC-F868EFF4AC77Q46216898-2FADE5D5-72FE-4045-A591-4F6A36015C4EQ47098257-1569A5E3-6B9B-47CF-836F-2F4AF3389A47Q47118957-91DF716D-A1FF-4E11-AB5C-0A5E10A30932Q47551124-B4AC2A11-066A-489D-B393-1F3E2DA96B13Q51149698-2B7C3BAC-B228-4164-A709-1BC5F58D7C60Q51474863-A1A66CF8-1CD4-45CF-9D6F-5FC6F7BF836EQ51530091-7D7DAE5B-9EE2-414B-AD9F-F9E52022B3D9Q55381566-E93A66D9-C058-4D2D-BCB4-B59669A419A6
P2860
Are survivors of acute lymphoblastic leukemia (ALL) at increased risk of cardiovascular disease?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Are survivors of acute lymphob ...... isk of cardiovascular disease?
@en
Are survivors of acute lymphoblastic leukemia
@nl
type
label
Are survivors of acute lymphob ...... isk of cardiovascular disease?
@en
Are survivors of acute lymphoblastic leukemia
@nl
prefLabel
Are survivors of acute lymphob ...... isk of cardiovascular disease?
@en
Are survivors of acute lymphoblastic leukemia
@nl
P356
P1476
Are survivors of acute lymphob ...... isk of cardiovascular disease?
@en
P2093
Kevin C Oeffinger
P2860
P304
462-7; discussion 468
P356
10.1002/PBC.21410
P433
P577
2008-02-01T00:00:00Z